Stay in touch
Prime news from our network.
#read
UKL is the first centre in Saxony to receive approval for gene therapy for haemophilia
The Haemophilia Centre at Leipzig University Hospital is the first centre in Saxony to receive approval for the use of gene therapies in patients with blood clotting disorders. The department, headed by Prof Dr Sirak Petros, is thus expanding its medical services to include a pioneering treatment option.
11/03/2025
So far, those affected have mainly been treated with regular injections of coagulation factors or replacement substances. Gene therapy now enables a one-off treatment in which the defective gene is introduced into the liver cells with the help of harmless viruses. In future, patients will be able to produce the missing coagulation factor themselves. Studies have shown good long-term results, particularly in people with haemophilia B. The therapy requires close medical supervision, but offers the chance of a life without regular medication. With the authorisation, the UKL can also treat patients from other institutions - an important step for care throughout Saxony.
Press release Leipzig University Hospital from 11 March 2025
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.